SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 27, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-19-007523.pdf 0000919574-19-007523.rtf
Nov 22, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-19-007431.pdf 0000919574-19-007431.rtf
Nov 18, 2019	An amendment to a SC 13D filing	SC 13D/A	View HTML 0000919574-19-007335.pdf 0000919574-19-007335.rtf 0000919574-19-007335.xls
Nov 18, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-19-007337.pdf 0000919574-19-007337.rtf
Nov 14, 2019	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-19-011046.pdf 0001558370-19-011046.rtf 0001558370-19-011046.xls
Nov 14, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001558370-19-011067.pdf 0001558370-19-011067.rtf 0001558370-19-011067.xls EX-101.INS - EX-101.INS
Nov 14, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-19-007137.pdf 0001214659-19-007137.rtf 0001214659-19-007137.xls
Nov 13, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0000919574-19-006929.pdf 0000919574-19-006929.rtf
Nov 08, 2019	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001235802-19-000132.pdf 0001235802-19-000132.rtf
Nov 06, 2019	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-19-060501.pdf 0001104659-19-060501.rtf 0001104659-19-060501.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE